Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: review and current status.

Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: review and current status.

Item
http://www.wikidata.org/entity/Q34119518
Analyses of the Binding between Water Soluble C60 Derivatives and Potential Drug Targets through a Molecular Docking ApproachRivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.Rivastigmine blocks voltage-activated K+ currents in dissociated rat hippocampal neurons.In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors.The discovery of new acetylcholinesterase inhibitors derived from pharmacophore modeling, virtual screening, docking simulation and bioassays.Novel N-allyl/propargyl tetrahydroquinolines: Synthesis via Three-component Cationic Imino Diels-Alder Reaction, Binding Prediction, and Evaluation as Cholinesterase Inhibitors.A review on cholinesterase inhibitors for Alzheimer's disease.Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological TreatmentThe Discovery of Pyridone and Pyridazone Heterocycles as γ-Secretase Modulators.[Pharmacotherapy of dementia. Pharmacologic and therapeutic activity of antidementia agents].Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis.Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans.Alzheimer's Disease and Medicinal Plants: An Overview.Computational evidence to inhibition of human acetyl cholinesterase by withanolide a for Alzheimer treatment.Application of response surface methodology to optimize the extraction of acetylcholinesterase inhibitors from Rhodiola sachalinensis
P2860

Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: review and current status.

Item
http://www.wikidata.org/entity/Q34119518
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Rivastigmine, a brain-region s ...... se: review and current status.
@ast
Rivastigmine, a brain-region s ...... se: review and current status.
@en
Rivastigmine, a brain-region s ...... se: review and current status.
@nl
type
label
Rivastigmine, a brain-region s ...... se: review and current status.
@ast
Rivastigmine, a brain-region s ...... se: review and current status.
@en
Rivastigmine, a brain-region s ...... se: review and current status.
@nl
prefLabel
Rivastigmine, a brain-region s ...... se: review and current status.
@ast
Rivastigmine, a brain-region s ...... se: review and current status.
@en
Rivastigmine, a brain-region s ...... se: review and current status.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Rivastigmine, a brain-region s ...... se: review and current status.
@en
P2093
P2860
P304
P31
P356
10.1517/13543784.8.10.1673
P407
P433
P478
P577
P698
P921